Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$10,311,946
-$1,313,679 QoQ
Shares Held
428,237
+3.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.53%
of 13F equity value
Holder Rank
#419
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gilman Hill Asset Management, LLC holds $40,633,070 across 8 Drug Manufacturers - General names. PFE ranks #2 (25.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
231,255 | $13,324,913 | |
| 2 | PFE |
Pfizer Inc
This page
|
428,237 | $10,311,946 | |
| 3 | GSK |
GSK plc
|
128,768 | $6,750,018 | |
| 4 | ABBV |
AbbVie Inc.
|
13,594 | $3,420,794 | |
| 5 | JNJ |
Johnson & Johnson
|
12,793 | $3,249,038 | |
| 6 | LLY |
ELI LILLY & Co
|
1,606 | $1,926,284 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,457 | $1,343,724 | |
| 8 | AMGN |
Amgen Inc
|
846 | $306,353 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,311,946 | 428,237 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $11,625,625 | 414,018 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $9,938,934 | 399,154 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $10,451,590 | 410,188 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $9,746,394 | 402,079 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $10,095,861 | 398,416 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $8,778,883 | 330,904 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $8,082,913 | 279,299 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $7,494,331 | 267,846 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $7,185,529 | 258,938 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $6,976,795 | 242,334 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $8,379,936 | 252,636 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $9,084,829 | 247,678 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $9,841,368 | 241,210 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $11,585,825 | 226,109 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $10,269,027 | 234,667 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $11,798,427 | 225,032 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $10,948,319 | 211,480 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $13,836,536 | 234,319 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $9,536,478 | 221,727 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $8,721,989 | 222,727 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $5,758,867 | 158,953 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $4,559,838 | 123,875 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $4,520,811 | 123,183 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $3,733,101 | 114,162 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $3,738,417 | 114,535 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||